Gaglia, J. L., Daley, H. L., Bryant, N. K., Ritz, J., Dong, T., Skyler, J. S., & Jiang, H. (2024). Novel Autologous Dendritic Cell Therapy AVT001 for Type 1 Diabetes. NEJM Evidence, 3(7). https://doi.org/10.1056/evidoa2300238

Thummar, K., & Rathinam, C. V. (2022). Class I PI3K regulatory subunits control differentiation of dendritic cell subsets and regulate Flt3L mediated signal transduction. Scientific Reports, 12(1). https://doi.org/10.1038/s41598-022-16548-x

Anandakumaran, P. N., Ayers, A. G., Muranski, P., Creusot, R. J., & Sia, S. K. (2022). Rapid video-based deep learning of cognate versus non-cognate T cell-dendritic cell interactions. Scientific Reports, 12(1). https://doi.org/10.1038/s41598-021-04286-5

Huang, J. J., Gaines, S. B., Amezcua, M. L., Lubell, T. R., Dayan, P. S., Dale, M., Boneparth, A. D., Hicar, M. D., Winchester, R., & Gorelik, M. (2022). Upregulation of type 1 conventional dendritic cells implicates antigen cross-presentation in multisystem inflammatory syndrome. Journal of Allergy and Clinical Immunology, 149(3), 912–922. https://doi.org/10.1016/j.jaci.2021.10.015

Korenfeld, D., Roussak, K., Dinkel, S., Vogel, T. P., Pollack, H., Levy, J., Leiding, J. W., Milner, J., Cooper, M., & Klechevsky, E. (2021). STAT3 Gain-of-Function Mutations Underlie Deficiency in Human Nonclassical CD16+ Monocytes and CD141+ Dendritic Cells. The Journal of Immunology, 207(10), 2423–2432. https://doi.org/10.4049/jimmunol.2000841

Castellanos, C. A., Ren, X., Gonzalez, S. L., Li, H. K., Schroeder, A. W., Liang, H.-E., Laidlaw, B. J., Hu, D., Mak, A. C. Y., Eng, C., Rodríguez-Santana, J. R., LeNoir, M., Yan, Q., Celedón, J. C., Burchard, E. G., Zamvil, S. S., Ishido, S., Locksley, R. M., Cyster, J. G., … Shin, J.-S. (2021). Lymph node–resident dendritic cells drive TH2 cell development involving MARCH1. Science Immunology, 6(64). https://doi.org/10.1126/sciimmunol.abh0707